Boston Scientific

By person

42 insiders · 447 transactions

55.0×

Michael F. Mahoney holds 55.0 times base salary in stock. $79.35M of shares against $1.44M in salary for 2025.

Salary from the company's own proxy. The shares are what Michael F. Mahoney last reported holding, valued at $49.22, the price Common Stock was last bought or sold at on the open market here, on 25 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Mahoney Michael F

Chairman, President & CEO

$9.00M (1)

$210.83M (29) scheduled

−$201.83M

1,612,143

0.1112%

$79.35M

+20.7%

Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

$4.51K (1)

$75.17M (25) scheduled

−$75.17M

278,105

0.0192%

$13.69M

+91.2%

Butcher Arthur C

EVP& Grp Pres, MedSurg & APAC

—

$60.26M (23) scheduled

−$60.26M

77,092

0.0053%

$3.79M

+347.1%

Brennan Daniel J.

EVP and CFO

—

$43.38M (26) scheduled

−$43.38M

225,808

0.0156%

$11.11M

+47.3%

Mirviss Jeffrey B.

EVP&Pres, Periph Intervent

—

$29.78M (39) scheduled

−$29.78M

25,766

0.0018%

$1.27M

−65.3%

Carruthers Wendy

EVP, Human Resources

—

$20.71M (45) scheduled

−$20.71M

29,308

0.0020%

$1.44M

−67.3%

Thepaut Eric Francis Yves

EVP & Pres, Eur, Mid-East, Afr

—

$14.70M (13)

−$14.70M

31,422

0.0022%

$1.55M

−73.3%

Pierce David A

EVP Pres MedSurg

—

$14.18M (71) scheduled

−$14.18M

0.0000%

$0.00

−100.0%

Nanavaty Maulik

SVP & Pres, Neuromodulation

—

$13.62M (21) scheduled

−$13.62M

177,258

0.0122%

$8.72M

−1.7%

Sorenson John Bradley

EVP, Global Operations

—

$11.91M (30) scheduled

−$11.91M

18,705

0.0013%

$920.65K

+48.3%

Bose Supratim

EVP & President, Asia-Pacific

—

$10.11M (2) scheduled

−$10.11M

320,301

0.0221%

$15.77M

+29.1%

Ballinger Kevin J.

EVP & Pres, Interven Cardio

—

$9.46M (17) scheduled

−$9.46M

80,085

0.0055%

$3.94M

+56.6%

Phalen Michael P.

EVP & President, MedSurg

—

$6.65M (11) scheduled

−$6.65M

133,373

0.0092%

$6.56M

+46.0%

Mackey Edward F

EVP, Operations

—

$6.38M (3)

−$6.38M

52,944

0.0037%

$2.61M

+267.5%

Brown Vance R

EVP, GC and Corp. Secretary

—

$5.26M (7) scheduled

−$5.26M

54,244

0.0037%

$2.67M

+97.7%

Pratt Timothy A.

EVP, GC & Chief Admin Officer

—

$4.97M (15)

−$4.97M

154,681

0.0107%

$7.61M

−39.7%

Zane Ellen M

Director

—

$3.99M (4) scheduled

−$3.99M

27,934

0.0019%

$1.37M

+212.7%

LUDWIG EDWARD J

Director

$430.31K (2)

$3.73M (6)

−$3.30M

30,359

0.0021%

$1.49M

+45.8%

Dawkins Keith D

EVP, Global Chief Med. Off.

—

$2.78M (2)

−$2.78M

68,165

0.0047%

$3.36M

−54.6%

Woodworth Emily

SVP, Global Controller and CAO

—

$1.92M (4) scheduled

−$1.92M

5,789

0.0004%

$284.93K

+26.6%

Wang Xin Warren

SVP and Pres, Asia Pacific

—

$1.53M (4)

−$1.53M

78,985

0.0055%

$3.89M

−16.1%

Connors Nelda J

Director

—

$1.48M (2)

−$1.48M

36,069

0.0025%

$1.78M

+11.6%

Monson Jonathan

EVP and CFO

—

$1.41M (5) scheduled

−$1.41M

48,971

0.0034%

$2.41M

+85.9%

Eddy Jodi Euerle

SVP, Chief Info & Digital Off.

—

$1.36M (8)

−$1.36M

23,263

0.0016%

$1.14M

+35.5%

Scanlon Meghan

SVP,Pres,Urology Pelvic Health

—

$1.35M (2) scheduled

−$1.35M

24,461

0.0017%

$1.20M

+185.1%

Dockendorff Charles J

Director

—

$1.15M (2) scheduled

−$1.15M

2,901

0.0002%

$142.79K

—

WICHMANN DAVID S

Director

$1.05M (1)

—

+$1.05M

45,382

0.0031%

$2.23M

—

Meredith Ian T

EVP Global Chief Med Officer

—

$591.01K (2)

−$591.01K

28,082

0.0019%

$1.38M

+3,866%

FUJIMORI YOSHIAKI

Director

—

$538.47K (2)

−$538.47K

2,081

0.0001%

$102.43K

−66.1%

Habiger David C

Director

$407.92K (5)

—

+$407.92K

17,160

0.0012%

$844.61K

+12,157%

Ralls-Morrison Desiree

SVP, GC and Corp Secretary

—

$376.07K (3)

−$376.07K

29,909

0.0021%

$1.47M

+1,278%

Olson Scott

SVP & Pres, CRM, Diagnostics

—

$173.67K (6)

−$173.67K

14,518

0.0010%

$714.57K

+23.6%

Morano Susan E

Director

$100.41K (1)

—

+$100.41K

13,784

0.0010%

$678.44K

—

Pegus Cheryl

Director

$99.99K (1)

—

+$99.99K

1,770

0.0001%

$87.12K

—

Sununu John E

Director

$1.93K (3)

$2.51K (1)

−$579.06

54,723

0.0038%

$2.69M

+319.5%

ROUX DAVID J

Director

—

73,591

0.0051%

$3.62M

+99.5%

JAMES DONNA

Director

—

21,879

0.0015%

$1.08M

+149.8%

O'Sullivan Miriam

SVP, Chief HR Officer

—

19,033

0.0013%

$936.79K

+38.5%

Mega Jessica L

Director

—

12,035

0.0008%

$592.36K

—

MACMILLAN STEPHEN P

Director

—

8,000

0.0006%

$393.76K

+743.9%

O'Connor Padraig Andrew

EVP, Global Operations

—

7,892

0.0005%

$388.44K

+90.2%

Weber Christophe Pierre

Director

—

3,786

0.0003%

$186.35K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Zane Ellen M

6 Nov 2025

Director

Sold on a plan

12,891

$98.28

$1.27M

Zane Ellen M

28 Oct 2025

Director

Sold on a plan

2,901

$102.24

$296.60K

Zane Ellen M

27 Oct 2025

Director

Sold on a plan

9,990

$101.13

$1.01M

Brown Vance R

21 May 2025

SVP, GC and Corp. Secretary

Sold on a plan

4,826

$106.42

$513.58K

Sorenson John Bradley

5 May 2025

EVP, Global Operations

Sold on a plan

4,572

$104.54

$477.96K

Brown Vance R

21 Apr 2025

SVP, GC and Corp. Secretary

Sold on a plan

4,826

$95.09

$458.90K

Brown Vance R

21 Mar 2025

SVP, GC and Corp. Secretary

Sold on a plan

4,826

$100.85

$486.70K

Woodworth Emily

4 Mar 2025

SVP, Global Controller and CAO

Sold on a plan

482

$104.63

$50.43K

Mirviss Jeffrey B.

25 Feb 2025

EVP&Pres, Periph Intervent

Sold on a plan

2,688

$104.00

$279.55K

Zane Ellen M

24 Feb 2025

Director

Sold on a plan

13,586

$104.23

$1.42M

Mirviss Jeffrey B.

24 Feb 2025

EVP&Pres, Periph Intervent

Sold on a plan

4,675

$104.25

$487.37K

Brown Vance R

21 Feb 2025

SVP, GC and Corp. Secretary

Sold on a plan

4,826

$104.64

$504.99K

Mirviss Jeffrey B.

19 Feb 2025

EVP&Pres, Periph Intervent

Sold on a plan

1,510

$105.35

$159.08K

Sorenson John Bradley

19 Feb 2025

EVP, Global Operations

Sold on a plan

3,303

$105.19

$347.44K

Brennan Daniel J.

18 Feb 2025

EVP and CFO

Sold on a plan

14,630

$104.67

$1.53M

Brennan Daniel J.

18 Feb 2025

EVP and CFO

Sold on a plan

2,900

$104.08

$301.82K

Sorenson John Bradley

18 Feb 2025

EVP, Global Operations

Sold on a plan

2,657

$104.41

$277.42K

Mirviss Jeffrey B.

12 Feb 2025

EVP&Pres, Periph Intervent

Sold on a plan

13,022

$105.06

$1.37M

Sorenson John Bradley

12 Feb 2025

EVP, Global Operations

Sold on a plan

6,389

$105.06

$671.25K

Sorenson John Bradley

7 Feb 2025

EVP, Global Operations

Sold on a plan

6,528

$104.97

$685.24K

Brennan Daniel J.

3 Jan 2025

EVP and CFO

Sold on a plan

9,689

$89.86

$870.64K

Mirviss Jeffrey B.

3 Jan 2025

EVP&Pres, Periph Intervent

Sold on a plan

7,152

$89.86

$642.66K

Sorenson John Bradley

3 Jan 2025

EVP, Global Operations

Sold on a plan

2,342

$89.86

$210.45K

Sorenson John Bradley

2 Jan 2025

EVP, Global Operations

Sold on a plan

4,119

$90.02

$370.79K

Fitzgerald Joseph Michael

28 Aug 2024

EVP & Group Pres, Cardiology

Sold on a plan

14,132

$80.00

$1.13M

Brennan Daniel J.

23 May 2024

EVP and CFO

Sold on a plan

47,621

$75.11

$3.58M

Dockendorff Charles J

7 May 2024

Director

Sold on a plan

3,946

$72.70

$286.87K

Mirviss Jeffrey B.

18 Mar 2024

EVP&Pres, Periph Intervent

Sold on a plan

14,506

$66.45

$963.93K

Mirviss Jeffrey B.

21 Feb 2024

EVP&Pres, Periph Intervent

Sold on a plan

4,960

$66.35

$329.10K

Mirviss Jeffrey B.

3 Jan 2024

EVP&Pres, Periph Intervent

Sold on a plan

11,931

$57.82

$689.86K

Mirviss Jeffrey B.

6 Dec 2023

EVP&Pres, Periph Intervent

Sold on a plan

353

$55.03

$19.43K

Mirviss Jeffrey B.

29 Aug 2023

EVP&Pres, Periph Intervent

Sold on a plan

4,657

$54.50

$253.81K

Mirviss Jeffrey B.

28 Aug 2023

EVP&Pres, Periph Intervent

Sold on a plan

13,971

$53.14

$742.42K

Brown Vance R

25 Aug 2023

SVP, GC and Corp. Secretary

Sold on a plan

15,750

$50.52

$795.76K

Dockendorff Charles J

18 Aug 2023

Director

Sold on a plan

17,079

$50.74

$866.63K

Showing 250 of 447 transactions. The figures above use every one of them.

By person

Individual transactions

What was left out